Reaction
Eosinophil Count Abnormal reporting signals
As of the last recalculation, Eosinophil Count Abnormal appears in 736 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 279.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 114 | 279.9 | 282.3 |
| Mepolizumab | 227 | 186.4 | 187.2 |
| Benralizumab | 59 | 90.6 | 90.8 |
| Ipratropium Bromide | 62 | 53.6 | 53.7 |
| Tiotropium Bromide | 164 | 43.3 | 43.3 |
| Budesonide And Formoterol Fumarate Dihydrate | 124 | 43.2 | 43.3 |
| Fluticasone Propionate And Salmeterol Xinafoate | 77 | 40.4 | 40.4 |
| Fluticasone Furoate And Vilanterol Trifenatate | 39 | 32.3 | 32.4 |
| Montelukast Sodium | 111 | 30.2 | 30.2 |
| Fluticasone Propionate Nasal | 30 | 29.1 | 29.2 |
| Theophylline Anhydrous | 11 | 25.5 | 25.5 |
| Theophylline | 10 | 24.9 | 25.0 |
| Fluticasone Furoate | 10 | 23.7 | 23.7 |
| Omalizumab | 60 | 21.6 | 21.6 |
| Montelukast | 57 | 20.7 | 20.7 |
| Quetiapine Fumarate | 21 | 20.7 | 20.7 |
| Tiotropium Bromide Inhalation Spray | 7 | 17.8 | 17.8 |
| Acetaminophen And Codeine | 7 | 16.4 | 16.4 |
| Alpelisib | 4 | 13.0 | 13.0 |
| Dornase Alfa | 4 | 5.8 | 5.8 |
| Dupilumab | 61 | 3.8 | 3.8 |